The prefix C83 specifically denotes non-Hodgkin lymphoma, which is then subdivided by the subsequent two digits that indicate the predominant cell type. 3 (Diffuse Large B-Cell Lymphoma) triggers a protocol for immediate, intensive chemotherapy, whereas a code for an indolent disease like C83.
Specific Entity Identification in B Cell Lymphoma ICD 10 Coding
Clinical Implications of Specific ICD 10 Classifications The choice of ICD 10 code directly influences the clinical pathway for the patient. Furthermore, specific codes are linked to eligibility for particular clinical trials and novel immunotherapies, making the correct documentation a critical component of modern oncologic care.
1 Indolent; often presents with advanced stage disease. Common Subtypes and Their Corresponding Codes Translating a pathologic diagnosis into the correct alphanumeric sequence requires familiarity with the most prevalent entities encountered in clinical practice.
Specific Entity Identification in B Cell Lymphoma ICD 10 Coding
While the C83 prefix is reserved for non-Hodgkin B cell malignancies, Hodgkin lymphoma uses the prefix C81 and is further defined by the presence of Reed-Sternberg cells. 1 Indolent; involves bone marrow and peripheral blood.
More About B cell lymphoma icd 10
Looking at B cell lymphoma icd 10 from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on B cell lymphoma icd 10 can make the topic easier to follow by connecting earlier points with a few simple takeaways.
